A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/11/1997	CA2257531A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides
12/11/1997	CA2257389A1 Virus-like particles useful as a vector for delivering nucleic acid
12/11/1997	CA2257299A1 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for production of a medicament for the normalization of serum lipids
12/11/1997	CA2257296A1 Anti-viral compounds
12/11/1997	CA2257279A1 Compositions and method which retard the aging process and which improve age-related disease conditions
12/11/1997	CA2257261A1 7-deoxy-6-substituted paclitaxels
12/11/1997	CA2257257A1 Aqueous nacreous lustre concentrate
12/11/1997	CA2257240A1 Fragments of leptin (ob protein)
12/11/1997	CA2257225A1 Membrane incorporation of texaphyrins
12/11/1997	CA2257206A1 Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
12/11/1997	CA2257174A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
12/11/1997	CA2257084A1 Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
12/11/1997	CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof
12/11/1997	CA2256721A1 A nasal spray containing an intranasal steroid and an antihistamine
12/11/1997	CA2256720A1 Formulation and method for treating congestive heart failure
12/11/1997	CA2256653A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
12/11/1997	CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/11/1997	CA2254997A1 Anti-viral compounds
12/11/1997	CA2254993A1 Anti-viral compounds
12/11/1997	CA2254957A1 Imidazole-substituted quinoxalinedione derivatives
12/11/1997	CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression
12/11/1997	CA2254757A1 1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor
12/11/1997	CA2254716A1 Dietetic foods containing conjugated linoleic acids
12/11/1997	CA2252417A1 Peptide derivatives
12/11/1997	CA2228444A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
12/10/1997	EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same
12/10/1997	EP0811635A1 Intravascular membrane thickening inhibitor
12/10/1997	EP0811634A1 Fluorinated sialyl-lewis x derivatives and intermediates for synthesis thereof
12/10/1997	EP0811623A1 Xanthine derivatives with end-aminated alkynol side chains
12/10/1997	EP0811622A1 3-(Piperi-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them
12/10/1997	EP0811621A2 Carbamoyl substituted oxazoles as thromboxane receptor antagonists
12/10/1997	EP0811616A1 Salts of 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester
12/10/1997	EP0811613A1 Antibiotic Quinolones and derivatives
12/10/1997	EP0811610A1 Ortho-substituted benzoylguanidines process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/10/1997	EP0811600A2 Anti-viral compounds
12/10/1997	EP0811599A2 Anti-viral compounds
12/10/1997	EP0811386A2 Method of selecting a salt for making an inclusion complex
12/10/1997	EP0811381A1 A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof
12/10/1997	EP0811380A2 Use of vanadiumcompositions for lowering blood sugar levels
12/10/1997	EP0811379A1 Therapeutic agent for dermatosis
12/10/1997	EP0811378A1 Preventive/remedy for interstitial pneumonia, inflammatory intestinal diseases or vascular thickening containing quinolizinone compounds, salt thereof or hydrates therefor
12/10/1997	EP0811377A1 Thrombolytic agent
12/10/1997	EP0811376A1 Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of chronic inflammatory bowel diseases
12/10/1997	EP0811375A1 Glutamic acid receptor agonist
12/10/1997	EP0811374A1 Combination dosage form comprising cetirizine and pseudoephedrine
12/10/1997	EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library
12/10/1997	EP0811075A1 A method for the isolation and purification of lipid cell-wall components
12/10/1997	EP0811073A2 Methods and compositions for administering gene therapy vectors
12/10/1997	EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/10/1997	EP0811061A1 Multiple-tumor aberrant growth genes
12/10/1997	EP0811011A1 Carbohydrate conjugated bio-active compounds
12/10/1997	EP0811009A1 Stable hydrates of a cephalosporin chloride salt
12/10/1997	EP0811008A1 Bicyclic benzazepine derivatives as vasopressin antagonists
12/10/1997	EP0811006A1 Benzopyran-containing compounds and method for their use
12/10/1997	EP0811002A2 Benzylpiperidines and piperazines as muscarinic antagonists
12/10/1997	EP0811001A1 Benzothiazine dioxides as endothelin antagonists
12/10/1997	EP0810994A1 Fibrinogen receptor antagonists
12/10/1997	EP0810991A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
12/10/1997	EP0810989A1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
12/10/1997	EP0810884A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
12/10/1997	EP0810883A2 Individual medicament dosing conjugate
12/10/1997	EP0810881A1 Delivery of therapeutic agents by gene therapy
12/10/1997	EP0810879A1 Preparation and use of a specific gaba-aalpha5 receptor ligand for treatment of alzheimer's disease
12/10/1997	EP0810878A2 Rna photocleavage using texaphyrins
12/10/1997	EP0810873A1 Antiviral combinations of bch-189 and ritonavir
12/10/1997	EP0810866A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment
12/10/1997	EP0810865A1 Novel pharmaceutical composition
12/10/1997	EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity
12/10/1997	EP0810863A1 Method of treating adenosine depletion
12/10/1997	EP0810862A2 Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks
12/10/1997	EP0810860A1 Method of use of radicicol for treatment of inflammation and endotoxemia
12/10/1997	EP0810859A1 Method of treatment of traumatic brain injury
12/10/1997	EP0810855A1 Polyalkylene block copolymers as surface modifiers for nanoparticles
12/10/1997	EP0810854A1 Aerosols containing beclomethazone nanoparticle dispersions
12/10/1997	EP0810853A1 Aerosols containing nanoparticle dispersions
12/10/1997	EP0810829A1 Amino acid compositions and use thereof in clinical nutrition
12/10/1997	EP0810823A1 Composition for controlling parasites
12/10/1997	EP0781135A4 Codeine containing formulations
12/10/1997	EP0761203B1 Use of cysteine acid homocysteine for enhancing the desquamation of the skin or to stimulate the renewal of the epidermis
12/10/1997	EP0708766B1 Use of coumarins as pla 2-inhibitors, new coumarins, process for preparing the same and medicaments
12/10/1997	EP0693071B1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use
12/10/1997	EP0674625B1 Amino-substituted pyrazoles having crf antagonistic activity
12/10/1997	EP0659193B1 Platelet aggregation inhibitors
12/10/1997	EP0659180B1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin)
12/10/1997	EP0641302B1 Alcohols as potassium channel openers and in treatment of urinary incontinence
12/10/1997	EP0570575B1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation
12/10/1997	EP0417209B1 Compositions and methods for administering therapeutically active compounds
12/10/1997	EP0355088B1 Sulphated polysaccharides having anti-metastatic activity
12/10/1997	CN1167487A Oxazolyl-and thiazolylimidazo- and thienodiazepines and their use as medicaments
12/10/1997	CN1167486A 2-(pyrazol-3-yl) garbapenem derivatives
12/10/1997	CN1167484A Novel amidinonaphthyl derivative or salt thereof
12/10/1997	CN1167482A Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same
12/10/1997	CN1167481A Synthetic polyunsaturated fatty acid analogues
12/10/1997	CN1167444A Use of metal complexes as liver and gall bladder radiodiagnosis agent in CT scanning
12/10/1997	CN1167442A Composition for prevention and treatment of HIV-1 infection comprising at least two different HIV-1 reverse transcriptase inhibitors
12/10/1997	CN1167438A Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
12/10/1997	CN1167437A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
12/10/1997	CN1167111A Thiazolidinedione derivatives, method for preparing derivatives and pharmaceutical compositions containing same

1 ... 6714 6715 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 ... 7860